Integrated network pharmacology reveals the mechanism of action of Xianlinggubao prescription for inflammation in osteoarthritis
Abstract Background Osteoarthritis (OA), a leading cause of disability worldwide, is characterized by complex interactions between cartilage degradation and synovial inflammation. While NSAIDs are the primary treatment, their prolonged use exacerbates gastrointestinal risks and does not alter diseas...
| Published in: | BMC Complementary Medicine and Therapies |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-05-01
|
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12906-025-04928-5 |
